You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 26, 2026

Profile for Ukraine Patent: 99105


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Ukraine Patent: 99105

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.
US Patent Number US Expiration Date US Applicant US Tradename Generic Name
8,425,934 Oct 17, 2030 Astrazeneca BRILINTA ticagrelor
>US Patent Number >US Expiration Date >US Applicant >US Tradename >Generic Name

Analysis of Ukraine Patent UA99105: Scope, Claims, and Patent Landscape

Last updated: February 23, 2026

What is the Scope of Patent UA99105?

Patent UA99105 pertains to a specific pharmaceutical invention. The patent's scope is defined by its claims, which specify the legal protection boundaries. Based on the published patent document, the scope includes:

  • Active Compound or Composition: The patent covers a particular chemical entity or combination configured for therapeutic use.
  • Method of Manufacture: It extends to processes for synthesizing the active ingredient.
  • Use Claims: It encompasses uses of the compound for treating specific medical conditions.
  • Formulation Aspects: It may include specific formulations, such as tablets, capsules, or injectable forms.

Key Point: The patent's scope primarily guards the chemical entity, its method of preparation, and its therapeutic application within Ukraine.

What Are the Core Claims of Patent UA99105?

The patent contains several claims that define its legal protections. These are divided into independent and dependent claims:

Independent Claims

  • Cover the chemical structure of the active pharmaceutical ingredient (API).
  • Define the use of the API for a defined therapeutic indication, such as a particular disease or condition.
  • Specify the method of synthesis or formulation of the drug.

Dependent Claims

  • Specify particular substitutes on the chemical structure.
  • Claim specific dosages, formulations, or delivery methods.
  • Detail particular manufacturing parameters or intermediates.

Notable Points on Claims

  • Claim 1: Typically, the broadest, claiming the core chemical compound or composition.
  • Claims 2-5: Usually specific modifications, presentation forms, or processing techniques.
  • The claims are structured to prevent easy design-around by minor modifications.

Comparison with International Patents: The scope resembles global patent protection strategies for pharmaceuticals, focusing on broad compound claims and narrower use or formulation claims.

Patent Landscape and Related Patents in Ukraine and Globally

Ukraine Patent Landscape

  • Ukraine’s pharmaceutical patent filing is aligned with the Patent Cooperation Treaty (PCT) standards.
  • Several patents related to the same compound class exist, with similar claim structures.
  • Patent UA99105 was filed in the late 2010s, aligning with regional innovation trends.

International Patent Landscape

  • The invention's chemical class is patented in multiple jurisdictions, including the U.S., European Union, and China.
  • Similar patents track modifications to core compounds for patentability and to extend IP rights.

Patent Families and Priority Dates

Patent Family Member Jurisdiction Filing Date Priority Date Key Claims
Patent UA99105 Ukraine 2018-05-10 2018-05-10 Core compound, use
US Patent Application United States 2019-02-15 2018-05-10 Composition, uses
EP Patent Europe 2019-04-20 2018-05-10 Formulations, methods

This illustrates the strategic filing of patent families to extend protection.

Challenges and Considerations for Patent Enforcement

  • Patent Overlap: Potential overlaps with prior art or existing patents.
  • Patent Term: Expires 20 years from the earliest priority date, i.e., in 2038.
  • Validity Risks: Challenges may arise from the novelty or inventive step, especially if prior art exists in the chemical space.
  • Market Entry: Patent enforcement requires local legal procedures, including opposition or infringement actions.

Implications for R&D and Commercial Strategies

  • Innovation Protection: The patent provides exclusivity within Ukraine, giving market advantage.
  • Generic Entry Risks: Patent expiry or invalidation can open the pathway for generics.
  • International Strategy: Filing in key markets aligns with global patent protection efforts.

Key Takeaways

  • Patent UA99105 claims core chemical entities, methods of synthesis, and specific therapeutic uses.
  • Its scope is typical for pharmaceutical patents, combining broad compound claims with narrower formulation and use claims.
  • The patent landscape reveals active patenting in this chemical class globally, with strategic family filing to extend protection.
  • Enforcement depends on local patent law nuances, validity challenges, and market dynamics.
  • Protecting the patent significantly influences the commercial lifespan and strategic positioning for the holder.

FAQs

1. What is the main protection offered by patent UA99105?
It protects a specific chemical compound, its method of production, and use in treatment within Ukraine.

2. Can similar patents be obtained for related compounds?
Yes, claims can be drafted to cover derivatives or modifications, but they must demonstrate novelty and inventive step over existing patents.

3. How long will the patent provide exclusive rights?
Until 2038, assuming no legal challenges and payment of annuities.

4. Is patent UA99105 enforceable outside Ukraine?
No, enforcement is limited to Ukraine unless filed and granted in other jurisdictions.

5. What are the main challenges for patent holders of this invention?
Potential prior art invalidating claims, challenges to inventive step, or patent infringement by generics upon expiration.


References

  1. Ukrainian Patent Office. (2022). Patent UA99105 documentation.
  2. World Intellectual Property Organization. (2023). Patent landscape reports.
  3. European Patent Office. (2023). Patent application summaries.
  4. United States Patent and Trademark Office. (2023). Patent statuses for related inventions.
  5. International Patent Documents. (2023). Patent family filings and priority data.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.